October 03, 2015
Learn how to perform Stretta, how Stretta can help manage GERD in multiple patient profiles - especially those with GERD after bariatric surgery, and get the latest Stretta data.
In addition to the scientific sessions - be sure to visit Mederi booth 1341 in the ACS exhibit hall.
Read more for detailed information on schedule and location of scientific sessions.
Learn about Stretta at ACS2015 - Surgical Skills Hands-On and Panels on Bariatric GERD
July 20, 2015
Mederi has some great events, courses and medical meetings lined up for the fall - we look forward to seeing you anywhere from Los Angeles to Monaco!! Connect with us on twitter @StrettaTherapy or @MederiNews for the latest updates.
Stretta and Secca International Fall 2015 Meeting Schedule
July 20, 2015
International Key Opinion Leader and Stretta physician, Professor Serhat Bor will be hosting international training sessions at EGE University in Izmir Turkey. There are options of small group sessions or a special GI and Motility Course presented by Mederi, EGE University and MMS, which will include live Stretta and Secca cases.
Mederi Stretta and Secca International Training - Izmir Turkey
June 18, 2015
The American Society for Gastrointestinal Endoscopy (ASGE) has issued new Guidelines that cite Stretta as a viable treatment option for GERD. According to the Guidelines, Stretta was seen as safe, effective and durable, specifically stating: "Adverse events were infrequent and typically minor. The technique appears to durably relieve GERD symptoms for up to 10 years in the majority of patients." The document was prepared by the ASGE Standards of Practice Committee, approved by the ASGE Governing Board, and published in the June issue of Gastrointestinal Endoscopy.
Stretta Therapy Included in New ASGE Guidelines on Endoscopy in GERD.
READ MORE (LEAVE SITE)
May 29, 2015
A special presentation at Digestive Disease Week 2015 featured GERD experts weighing in on their successful experience using Stretta Therapy to treat challenging patient populations suffering from GERD.
Ronnie Fass, MD, of Case Western Reserve University moderated the discussion, and reviewed clinical data on Stretta. Expert panelists then addressed specific types of chronic GERD patients that Stretta has helped them treat. Speakers included: Dana Portenier, MD, Duke University School of Medicine (Stretta in GERD After Bariatric Surgery) - Hiroshi Mashimo, MD, PhD, VA Boston Healthcare/Harvard Medical School (Stretta in LPR Patients) - George Triadafilopoulos, MD, Stanford University School of Medicine (Stretta in Refractory GERD) - Mark Noar, MD, Heartburn and Reflux Study Center (Stretta in GERD After Anti-Reflux Surgery).
Dr. Portenier highlighted the challenge of treating bariatric patients with GERD, noting that Duke has introduced Stretta to treat obese patients with chronic GERD, especially those after Sleeve Gastrectomy. "This is an area where Stretta makes a lot of sense. These patients are generally unwilling to have their sleeve converted to a Gastric Bypass just to fix their GERD," Portenier said. "With Stretta they avoid additional surgery. In the outstanding results we are seeing at Duke, most Stretta patients see complete or partial resolution of symptoms and are able to get off PPIs." "Stretta is a very low risk endoscopic procedure for these patients," he added.
Discussing refractory GERD sufferers, Dr. Triadafilopoulos explained that these patients experience reflux despite PPI therapy. According to Dr. Triadafilopoulos, there is a large gap between those who don't adequately respond to PPIs and those who choose anti-reflux surgery. "Stretta spans this gap with an outpatient, endoscopic option that has been proven effective and safe for up to 10 years." He presented the case of a refractory GERD patient who underwent Stretta. "The patient experienced heartburn, chest pain and regurgitation despite diet changes and PPI therapy. Testing showed abnormal esophageal acid exposure despite twice daily PPI. Six-months after Stretta, the patient is asymptomatic except for occasional gastric discomfort after meals, is off PPIs, uses occasional antacids, and has a normal pH study."
Dr. Mashimo reviewed his experience with Stretta in laryngopharyngeal reflux (LPR), a condition with symptoms such as chronic cough, hoarseness, asthma and chest pain, often presenting without heartburn. Also called atypical or silent reflux, LPR is caused by a backflow of gastric contents into the pharynx. "Often, LPR patients don't respond well to PPIs and only about half improve after anti-reflux surgery." Mashimo elaborated with a patient example. "The patient had globus sensation and chronic cough, with non-seasonal asthma not responsive to medications. One month after Stretta, she experienced a marked improvement, and one year later the grateful patient had nearly complete resolution of symptoms, and was off PPIs."
Dr. Noar discussed the Stretta option for GERD after anti-reflux surgery (Nissen fundoplication), explaining that 10 years after a Nissen, studies show recurring GERD in up to 42 percent of patients. Reviewing failed Nissen patients from the Stretta 10-year study he noted, "A decade later, 64 percent of these patients were still off daily PPIs." He added, "Stretta treats the internal lower esophageal sphincter without altering the anatomy, important for those with prior surgery, and the only non-surgical option for this type of patient."
"These topics represent unmet needs in GERD treatment where Stretta may be an option to effectively treat chronic sufferers," Dr. Fass added.
DDW2015 Stretta Case Studies from the Experts - watch the presentation
READ MORE (LEAVE SITE)
May 15, 2015
Two milestones in the worldwide growth of Stretta make it the safest and most widely used non-surgical treatment for chronic GERD: 18,000 Stretta procedures have been performed since introduction, and international reach has been expanded with regulatory approvals added in large OUS markets.
Mederi’s Stretta Becomes World’s Most Widely-Used Non-Surgical Treatment For Chronic GERD
May 07, 2015
Join us for a special presentation at DDW2015 Product Theater, where GERD experts will weigh in on their experience with Stretta Therapy in difficult to treat patients.
DDW Product Theater Mon. May 18 - 1:15 Stretta Case Studies from the Experts
April 22, 2015
Presentation featured Key Opinion Leaders reviewing how Stretta is the ideal solution for GERD post-bariatric procedures and how non-ablative RF (NARF) treatments work in GERD and fecal incontinence.
SAGES Mederi Booth Presentation Recap
January 07, 2015
Studies show that 1 in 3 people suffer from gastroesophageal reflux disease (GERD). For many, medical management has not always been an effective way to manage GERD symptoms. At Duke, minimally invasive endoscopic and surgical treatments have proven to be safe, effective options to cure GERD for good. Join Dr. Dana Portenier for a discussion of available treatments including Stretta Therapy, and which one may be right for you. Follow the link or call 866-637-0711 to register. The first GERD seminar is scheduled for Tuesday January 13 from 6:30-7:30 pm.
GERD Seminar at Duke Medicine to Feature Stretta Therapy!
READ MORE (LEAVE SITE)
November 24, 2014
Jessica shares her long battle with chronic GERD for GERD Awareness Week
Jessica’s struggle with GERD and how she got healthy
Page 2 of 5 pages < 1 2 3 4 > Last ›